Frontiers in Oncology | Thoracic Oncology

Mini Review

Published on 21 Jul 2014

A Systemic Review of Resistance Mechanisms and Ongoing Clinical Trials in ALK-Rearranged Non-Small Cell Lung Cancer

in Thoracic Oncology

Khashayar Esfahani
Jason Scott Agulnik
Victor Cohen

Frontiers in Oncology

doi 10.3389/fonc.2014.00174

10,899 views
25 citations

Mini Review

Published on 21 Jul 2014

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

in Thoracic Oncology

Normand Blais
Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2014.00177

11,236 views
7 citations

Mini Review

Published on 16 Jul 2014

Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist’s Perspective

in Thoracic Oncology

Elisa Brega
Guilherme Brandao

Frontiers in Oncology

doi 10.3389/fonc.2014.00182

9,444 views
20 citations

Mini Review

Published on 10 Jul 2014

The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach

in Thoracic Oncology

David E. Dawe
Peter Michael Ellis

Frontiers in Oncology

doi 10.3389/fonc.2014.00178

8,168 views
13 citations

Mini Review

Published on 03 Jul 2014

Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?

in Thoracic Oncology

Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2014.00173

4,745 views
10 citations

Mini Review

Published on 27 Jun 2014

Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line

in Thoracic Oncology

Abdulaziz Al-Farsi
Peter Michael Ellis

Frontiers in Oncology

doi 10.3389/fonc.2014.00157

12,076 views
45 citations

Review

Published on 16 Jun 2014

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

in Thoracic Oncology

Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2014.00146

11,879 views
10 citations

General Commentary

Published on 07 May 2014

Novel Biologic Therapies for Thymic Epithelial Tumors

in Thoracic Oncology

Yuanbin Chen
Helen Gharwan
Anish Thomas

Frontiers in Oncology

doi 10.3389/fonc.2014.00103

5,538 views
11 citations

Review

Published on 14 Jan 2014

Surgical Approaches for Stage IVA Thymic Epithelial Tumors

in Thoracic Oncology

Mark Shapiro
Robert J Korst

Frontiers in Oncology

doi 10.3389/fonc.2013.00332

7,446 views
21 citations

Review

Published on 10 Jan 2014

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive

in Thoracic Oncology

Ritsuko Komaki
Daniel Gomez

Frontiers in Oncology

doi 10.3389/fonc.2013.00330

19,637 views
38 citations

Original Research

Published on 31 Dec 2013

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c

in Thoracic Oncology

Bei Huang
Djeda Belharazem
Li Li
Susanne Kneitz
Philipp Schnabel
Ralf Rieker
Daniel Körner
Winnfried Nix
Berthold Schalke
Hans Konrad Müller-Hermelink

Frontiers in Oncology

doi 10.3389/fonc.2013.00316

8,845 views
24 citations

Review

Published on 09 Oct 2013

Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy

in Thoracic Oncology

Marko Jakopovic
Anish Thomas
Sanjeeve Balasubramaniam
David Schrump
Giuseppe Giaccone
Susan E. Bates

Frontiers in Oncology

doi 10.3389/fonc.2013.00261

19,108 views
65 citations

Mini Review

Published on 09 Sep 2013

Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer

in Thoracic Oncology

Kenneth Huffman
Elisabeth D Martinez

Frontiers in Oncology

doi 10.3389/fonc.2013.00235

10,689 views
18 citations

Original Research

Published on 28 Aug 2013

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

in Thoracic Oncology

Yuhchyau Chen
James Moon
Kishan J Pandya
Derick HM Lau
Karen Kelly
Fred Hirsch
Laurie E Gaspar
Mary Redman
David Gandara

Frontiers in Oncology

doi 10.3389/fonc.2013.00219

5,870 views
12 citations

Original Research

Published on 09 Aug 2013

Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma

in Thoracic Oncology

Eva Darai-Ramqvist
Gustav Nilsonne
Carmen Flores-Staino
Anders Hjerpe
Katalin Dobra

Frontiers in Oncology

doi 10.3389/fonc.2013.00203

5,336 views
2 citations

Review

Published on 05 Aug 2013

Targeting Genomic Alterations in Squamous Cell Lung Cancer

in Thoracic Oncology

KALYAN MANTRIPRAGADA
Humera Khurshid

Frontiers in Oncology

doi 10.3389/fonc.2013.00195

10,265 views
16 citations

Perspective

Published on 29 Jul 2013

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)

in Thoracic Oncology

Richard L Momparler

Frontiers in Oncology

doi 10.3389/fonc.2013.00188

7,741 views
30 citations

Review

Published on 19 Jun 2013

Epigenetic Therapy in Lung Cancer – Role of microRNAs

in Thoracic Oncology

Sacha I Rothschild

Frontiers in Oncology

doi 10.3389/fonc.2013.00158

7,296 views
29 citations

Original Research

Published on 19 Jun 2013

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer

in Thoracic Oncology

Anne-Marie Baird
Eilis Dockry
Anne Daly
Emma Stack
Derek G. Doherty
Kenneth J. O'Byrne
Steven G. Gray

Frontiers in Oncology

doi 10.3389/fonc.2013.00162

9,285 views
18 citations

Review

Published on 30 May 2013

Epigenetic Therapy in Lung Cancer

in Thoracic Oncology

Stephen V Liu
Muller Fabbri
Barbara J. Gitlitz
Ite A. Laird-Offringa

Frontiers in Oncology

doi 10.3389/fonc.2013.00135

11,430 views
35 citations

Mini Review

Published on 06 Jan 2012

PI3K Pathway in NSCLC

in Thoracic Oncology

Alex Martínez Martí
Enriqueta Felip

Frontiers in Oncology

doi 10.3389/fonc.2011.00055

8,300 views
13 citations

Original Research

Published on 13 Dec 2011

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Ritsuko Komaki
Xiong Wei
Pamela K Allen
Zhongxing Liao
Luka Milas
James D Cox
Michael S O'Reilly
Joe Chang
Mary Frances McAleer
Melenda Jeter

Frontiers in Oncology

doi 10.3389/fonc.2011.00052

7,168 views
12 citations

Review

Published on 30 Nov 2011

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer

in Thoracic Oncology

William Thomas Sause
Breanne Terakedis

Frontiers in Oncology

doi 10.3389/fonc.2011.00047

6,027 views
12 citations

Perspective

Published on 24 Nov 2011

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer

in Thoracic Oncology

Manali Patel
Heather A Wakelee

Frontiers in Oncology

doi 10.3389/fonc.2011.00045

7,010 views
6 citations

1,970 articles

articles

A Systemic Review of Resistance Mechanisms and Ongoing Clinical Trials in ALK-Rearranged Non-Small Cell Lung Cancer

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist’s Perspective

The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach

Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?

Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

Novel Biologic Therapies for Thymic Epithelial Tumors

Surgical Approaches for Stage IVA Thymic Epithelial Tumors

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c

Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy

Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma

Targeting Genomic Alterations in Squamous Cell Lung Cancer

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)

Epigenetic Therapy in Lung Cancer – Role of microRNAs

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer

Epigenetic Therapy in Lung Cancer

PI3K Pathway in NSCLC

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer